Ocugen Inc. (NASDAQ: OCGN) Stock Information | RedChip

Ocugen Inc. (NASDAQ: OCGN) Listen to this Section


$1.25
-0.0600 ( -4.58% ) 3.9M

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Market Data


Open


$1.25

Previous close


$1.31

Volume


3.9M

Market cap


$356.94M

Day range


$1.23 - $1.31

52 week range


$0.35 - $2.11

Insider Ownership Transactions

Total Amount Purchased: -1,357,990.00 | $ -1,697,487.50

Date Type Amount Purchased Purchaser
2024-07-02 Sale -66929.00 WHITTINGTON MARNA C
2024-07-02 Sale -66929.00 Castillo Kirsten
2024-07-02 Sale -66929.00 Zhang Junge
2024-07-02 Sale -66929.00 Fernandes Prabhavathi
2024-07-02 Sale -917.00 Upadhyay Arun
2024-07-02 Sale -66929.00 Kompella Uday
2024-04-17 Sale -308465.00 Qamar Huma
2024-01-05 Sale -180204.00 Musunuri Shankar
2024-01-05 Sale -41633.00 Upadhyay Arun
2024-01-04 Sale -492126.00 Musunuri Shankar

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 35 Aug 13, 2024
8-k 8K-related 30 Aug 08, 2024
10-q Quarterly Reports 70 Aug 08, 2024
8-k 8K-related 20 Aug 05, 2024
8-k 8K-related 20 Aug 01, 2024
8-k 8K-related 14 Jul 08, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.